Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT)
JAC Antimicrob Resist
.
2023 Apr 17;5(2):dlad047.
doi: 10.1093/jacamr/dlad047.
eCollection 2023 Apr.
Authors
Mark Gilchrist
1
,
Conor Jamieson
2
,
Felicity Drummond
3
,
Tim Hills
4
,
R Andrew Seaton
5
,
Mark Santillo
6
Affiliations
1
Department of Pharmacy/Infection, Imperial College Healthcare NHS Trust, London, UK.
2
NHS England, Birmingham, UK.
3
British Society for Antimicrobial Chemotherapy (BSAC), Birmingham, UK.
4
Pharmacy Department, Nottingham University Hospitals NHS Trust, Nottingham, UK.
5
Department of Infectious Diseases, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.
6
Department of Pharmacy, University Hospitals Plymouth NHS Trust, Plymouth, UK.
PMID:
37077650
PMCID:
PMC10108881
DOI:
10.1093/jacamr/dlad047
No abstract available